Angelini pharma
  • Angelini Pharma Worldwide
    • Italy
    • Poland
    • Spain
  • Angelini Pharma
  • Who we are

    • Who We Are
    • Vision, mission & values
    • Key facts and events
    • People
  • Core areas

    • Mental Health
    • Central Nervous System
    • Rare Diseases
    • Consumer Health
  • From pipeline to health aids

    • Pipeline
    • Sites
  • Our Partnerships

    • Research & Academic Centers and Scientific Institutions
    • Partnering
  • Our Responsibility

    • Sustainability
    • Ethics
    • Quality policy
    • Transparency
  • Media

    • News
    • Press releases
    • Press kit
    • Magazine
    • Media center
  • Career Opportunities
  • Open main menu
  • Open main menu
  • Search

    Search

  1. Angelini Pharma
  2. Core areas
  3. Focus On

Focus On

Focus On
  • All articles
  • Mental Health
  • Pain
  • Rare Diseases
  • Consumer Health

Mental Health

  1. Mental health disorders: the borders and burden of the problem

    Mental health disorders (MHDs) affect one in four people at some stage during their lifetime. Thus, it is a condition that may affect all of us.

    Mental health disorders: the borders and burden of the problem
load more

See also

  1. Mental Health

    Mental Health
  2. Central Nervous System

    Central Nervous System
  3. Rare Diseases

    Rare Diseases
  4. Consumer Health

    Consumer Health
Angelini pharma
  • Terms of use
  • Privacy
  • Transparency
  • Cookie Policy
  • Contact
  • Site map
  • Credits
  • Twitter
  • Linkedin
  • Facebook
  • Instagram
  • YouTube
  • Top Employee

Angelini S.p.a. - Viale Amelia 70, 00181 Roma - P.IVA 01258691003 e C.F. Numero di iscrizione registro imprese: 03907010585 - Ufficio del registro delle imprese: Roma - Capitale: € 165.000.000 I.V.
Copyright 2021 © Angelini S.p.a. - All Rights Reserved

Close menu